Ying Xie,Liang Liu,Hua Zhou,Zhong-Wen Yuan,Yan-Fang Zheng,Sen-Ling Feng,Xiao-Hui Zeng,Hui Wang
申请号：
US15481720
公开号：
US20180289666A1
申请日:
2017.04.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A method for reducing abnormalities in lipid metabolism and for reducing inflammation in a subject suffering from an autoimmune inflammatory disease accompanied by abnormalities in lipid metabolism includes administering an effective amount of a flavonolignan to the subject. The subject may additionally suffer from a liver disease, obesity, hypertension, diabetes mellitus or a metabolic syndrome. Further provided is a method for reducing the risk of a cardiovascular disease in a subject suffering from an autoimmune inflammatory disease accompanied by abnormalities in lipid metabolism and a method for reducing hepatic abnormalities and reducing inflammation in a subject suffering from an autoimmune inflammatory disease accompanied by hepatic abnormalities. Still further provided is a method for reducing liver damages associated with the treatment of rheumatoid arthritis with a disease-modifying antirheumatic drug or a non-steroidal anti-inflammatory drug.
